Valerie Treyer
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (27)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Background Women are overrepresented among individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Biological (sex) as well as sociocultural (gender) differences between women and men might account for this imbalance, yet their impact on PASC is unknown. Aim We assessed the impact of sex and gender on PASC in a Swiss population. Method Our multicentre prospective cohort study included 2,856 (46% women, mean age 44.2 ± 16.8 years) outpatients and hospitalised patients with PCR-confirmed SARS-CoV-2 infection. Results Among those who remained outpatients during their first infection, women reported persisting symptoms more often than men (40.5% vs 25.5% of men; p < 0.001). This sex difference was absent in hospitalised patients. In a crude analysis, both female biological sex (RR = 1.59; 95% CI: 1.41–1.79; p < 0.001) and a score summarising gendered sociocultural variables (RR = 1.05; 95% CI: 1.03–1.07; p < 0.001) were significantly associated with PASC. Following multivariable adjustment, biological female sex (RR = 0.96; 95% CI: 0.74–1.25; p = 0.763) was outperformed by feminine gender-related factors such as a higher stress level (RR = 1.04; 95% CI: 1.01–1.06; p = 0.003), lower education (RR = 1.16; 95% CI: 1.03–1.30; p = 0.011), being female and living alone (RR = 1.91; 95% CI: 1.29–2.83; p = 0.001) or being male and earning the highest income in the household (RR = 0.76; 95% CI: 0.60–0.97; p = 0.030). Conclusion Specific sociocultural parameters that differ in prevalence between women and men, or imply a unique risk for women, are predictors of PASC and may explain, at least in part, the higher incidence of PASC in women. Once patients are hospitalised during acute infection, sex differences in PASC are no longer evident.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (18)
Henrik Zetterberg
Professor
University of Gothenburg
Catherine Gebhard
University of Zurich
Kris Thielemans
Professor in Medical Imaging Physics
University College London
Ahmed Haider
Emory University School of Medicine
Sandro Thomas Studer
University of Zurich
Antonio Giulio Gennari
University Children's Hospital Zurich
Susanne Wegener
University Hospital of Zurich
Matthias Preusser
Medical University
Caroline E. Gebhard
University Hospital Basel
Silvio Daniel Brugger
University of Zurich
Adrian Preda
University of California Irvine School of Medicine
Vera Regitz-Zagrosek
Director, Prof. dr. Dr.
Charité - Universitätsmedizin Berlin
Martina Sebök
University Hospital of Zurich
Philipp Antonio Kaufmann
Professor of Nuclear Medicine
University of Zurich
Ronny Ralf Buechel
University Hospital of Zurich
Ruiqing Ni
University of Zurich
Christian Kellenberger
University of Zurich
Joerg C. Schefold
University Hospital of Bern
Make your next move.
Prepare your application
Review drafts before you send them.